Keywords: nastech, files, nda, intranasal, scopolamine, filed, new

Nastech files NDA for intranasal scopolamine

Article | 21 December 1999

Print This

Nastech has filed a New Drug Application with the US Food and DrugAdministration, seeking approval to market intranasal scopolamine for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in